TrialLung cancer (Amsterdam, Netherlands)2024

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.

Aaron S Mansfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.